Research indicates that high-sensitivity C-reactive protein (hs-CRP) is a powerful predictor of heart attack risk, especially those caused by silent inflammation. The JUPITER trial demonstrated that individuals with elevated hs-CRP, even with normal cholesterol, benefited from statin therapy, reducing heart attack and stroke risk. Monitoring hs-CRP alongside cholesterol offers a more comprehensive cardiovascular assessment.This blood test can predict heart attack risk, and it’s not cholesterol
Research indicates that high-sensitivity C-reactive protein (hs-CRP) is a powerful predictor of heart attack risk, especially those caused by silent inflammation. The JUPITER trial demonstrated that individuals with elevated hs-CRP, even with normal cholesterol, benefited from statin therapy, reducing heart attack and stroke risk. Monitoring hs-CRP alongside cholesterol offers a more comprehensive cardiovascular assessment.